Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Gulnaz Kaishibayeva"'
Autor:
Saltanat Abdraimova, Zhanybek Myrzayev, Altynay Karimova, Altynay Talgatkyzy, Talgat Khaibullin, Gulnaz Kaishibayeva, Sandugash Elubaeva, Karlygash Esembekova, Dongrak Choi, Pablo Martinez-Martin, Christopher G. Goetz, Glenn T. Stebbins, Sheng Luo, Chingiz Shashkin, Nazira Zharkinbekova, Rauan Kaiyrzhanov
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 10, Iss , Pp 100232- (2024)
Background and Purpose: The International Movement Disorder Society revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely used in the assessment of the severity of Parkinson’s disease (PD). This study aimed to validate th
Externí odkaz:
https://doaj.org/article/496a5217de4d4eaa9b12774c741e89d4
Autor:
Rauan Kaiyrzhanov, Akbota Aitkulova, Jana Vandrovcova, David Murphy, Nazira Zharkinbekova, Chingiz Shashkin, Vadim Akhmetzhanov, Gulnaz Kaishibayeva, Altynay Karimova, Zhanybek Myrzayev, Malgorzata Murray, Talgat Khaibullin, John Hardy, Henry Houlden
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 6, Pp n/a-n/a (2021)
ABSTRACT Background Knowledge of the genetic background of many human diseases is currently lacking from genetically undiscovered regions, including Central Asia. Kazakhstan is the first Central Asian country where the genetic studies of Parkinson's
Externí odkaz:
https://doaj.org/article/cad4a07db35648faade6d7016496b8e2
Autor:
Rauan Kaiyrzhanov, Akbota Aitkulova, Chingiz Shashkin, Nazira Zharkinbekova, Mie Rizig, Elena Zholdybayeva, Zharkyn Jarmukhanov, Vadim Akhmetzhanov, Gulnaz Kaishibayeva, Talgat Khaibullin, Altynay Karimova, Serik Akshulakov, Askhat Bralov, Nurlan Kissamedenov, Zhanar Seidinova, Anjela Taskinbayeva, Aliya Muratbaikyzy, Henry Houlden
Publikováno v:
Parkinson's Disease, Vol 2020 (2020)
Background. LRRK2 mutations have emerged as the most prevalent and potentially treatable determinants of Parkinson’s disease (PD). Peculiar geographic distribution of these mutations has triggered an interest in genotyping PD cohorts of different e
Externí odkaz:
https://doaj.org/article/e1290314fb6d4c18a782d814d7b74bc4
Electroneurophysiological criteria of efficiency of pathogenetic therapy in diabetic polyneuropathy.
Autor:
Lubov Kuzina, Gulnaz Kaishibayeva
Publikováno v:
Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 4, Iss 42, Pp 39-45 (2016)
Purpose: to estimate efficiency of pathogenetic therapy of diabetic polyneuropathy with including of benfotiaminby means of an electroneuromyography. Materials: assessment of efficiency of pathogenetic therapy of diabetic polyneuropathy with includin
Externí odkaz:
https://doaj.org/article/4494573210e24a95bbf9bcf2b7390860
Autor:
Rauan Kaiyrzhanov, Mie Rizig, Akbota Aitkulova, Nazira Zharkinbekova, Chingiz Shashkin, Gulnaz Kaishibayeva, Altynay Karimova, Talgat Khaibullin, Dinara Sadykova, Manizha Ganieva, Khurshidakhon Rasulova, Henry Houlden
Publikováno v:
Parkinson's Disease, Vol 2019 (2019)
Our understanding of Parkinson’s disease (PD) has significantly accelerated over the last few years, but predominant advances have been made in developed, Western countries. Little is known about PD in the Central Asian (CA) and Transcaucasian (TC)
Externí odkaz:
https://doaj.org/article/e3f28fd22b6a4a5aa21ba47e3b83688a
Autor:
Saltanat, Serikbayeva, Gulbanu, Shaimerdenova, Namazbai, Оrmanov, Тalgat, Оrmanov, Gulzhan, Аbuova, Gulnaz, Kaishibayeva, Kanatzhan, Kemelbekov
Publikováno v:
Georgian Medical News; Jul/Aug2024, Vol. 352/353 Issue 7/8, p265-269, 5p
Publikováno v:
Journal "Medicine". 1:39-43
Essential tremor is one of the most common movement disorders. The nature of this disease is not fully understood. It was believed that this pathology manifests itself only by tremor, and symptoms such as depression, anxiety and apathy in patients wi
Autor:
Nurlan Kissamedenov, Serik Akshulakov, Vadim Akhmetzhanov, Henry Houlden, Chingiz Shashkin, Talgat Khaibullin, Altynay Karimova, Rauan Kaiyrzhanov, Zharkyn Jarmukhanov, Askhat Bralov, Anjela Taskinbayeva, Gulnaz Kaishibayeva, Aliya Muratbaikyzy, Zhanar Seidinova, Nazira Zharkinbekova, Akbota Aitkulova, Mie Rizig, Elena Zholdybayeva
Publikováno v:
Parkinson's Disease
Parkinson's Disease, Vol 2020 (2020)
Parkinson's Disease, Vol 2020 (2020)
Background. LRRK2 mutations have emerged as the most prevalent and potentially treatable determinants of Parkinson’s disease (PD). Peculiar geographic distribution of these mutations has triggered an interest in genotyping PD cohorts of different e
Autor:
Henry Houlden, Gulnaz Kaishibayeva, Talgat Khaibullin, John Hardy, Nazira Zharkinbekova, Akbota Aitkulova, Zhanybek Myrzayev, Chingiz Shashkin, Jana Vandrovcova, David Murphy, Altynay Karimova, Rauan Kaiyrzhanov, Malgorzata Murray, Vadim Akhmetzhanov
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 6, Pp n/a-n/a (2021)
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine
Background Knowledge of the genetic background of many human diseases is currently lacking from genetically undiscovered regions, including Central Asia. Kazakhstan is the first Central Asian country where the genetic studies of Parkinson's disease (
Autor:
Rauan Kaiyrzhanov, Talgat Khaibullin, Nazira Zharkinbekova, Mie Rizig, Chingiz Shashkin, Dinara Z. Sadykova, Henry Houlden, Zhanar Seidinova, Altynay Karimova, Anjela Taskinbayeva, Gulnaz Kaishibayeva, Vadim Akhmetzhanov
Publikováno v:
Journal of Parkinson's Disease